基于灰色多指标评价模型的江苏省生物医药产业集群竞争力研究  

Study on the Biological Pharmaceutical Industry Cluster Competitiveness in Jiangsu Province Based on Grey Multi-index Evaluation Model

作　　者：曹阳[1] 朱洁[1] 

机构地区：[1]中国药科大学国际医药商学院,南京211198

出　　处：《中国药房》2015年第19期2593-2597,共5页China Pharmacy

基　　金：江苏省软科学研究计划项目(No.BR2014065)

摘　　要：目的:建立适用于生物医药产业集群竞争力评价的指标体系,为评价江苏省生物医药产业集群竞争力的情况提供参考。方法:选取2012年江苏省生物医药产业集群企业为研究样本,通过问卷调查,采用灰色多指标评价方法确定权重集,构建评价样本矩阵,对创新知识溢出、创新网络组织、社会资本等3个一级指标(其中包含8个二级指标、23个三级指标)进行测评分析。结果与结论:江苏省生物医药产业集群的研发投入强度等资金相关指标偏低,存在资金短缺的问题;拥有自主知识产权的新药专利数不足,知识产权保护不力,存在自主创新动力不足的问题;产品销售率等效益性指标偏低,存在科研成果产业化不高的问题;社会文化得分在社会资本层面中不高,存在约束性的生物创新公共服务平台等软环境需要加强的问题。建议进一步加强集群企业与各科研机构之间的合作,提升企业创新动力;完善生物创新机制,提高科研成果产业化水平;积极引导各种类型的生物创新公共服务平台参与集群软环境的建设。OBJECTIVE：To establish the evaluation index system that is suitable for biological pharmaceutical industry cluster competitiveness,and provide reference for the evaluation of biological pharmaceutical industry cluster competitiveness in Jiangsu province.METHODS：Biological pharmaceutical industry cluster enterprises in Jiangsu province were selected as research samples.Through the questionnaires,the grey multi-index evaluation method was used to determine weight set,establish evaluation sample matrix,and evaluate and analyze 3 first-level indexes（8 second-level indexes,and 23 tertiary-level indexes）,such as the innovation knowledge spillover,innovation network and social capital,etc.RESULTS CONCLUSIONS：The financial indicators such as investment intensity of biological pharmaceutical industry cluster in Jiangsu province were low,and there was a shortage of funds problem;new drug patents of independent intellectual property rights were insufficient,and lacked of protection of intellectual property rights,there was an independent innovation motivation problem;profitability indexes such as the rate of product sales were low,there was a problem of low industrialization of scientific research;social culture score in social capital level was not high,there was a problem of strengthening soft environment such as the binding biological innovation public service platform.It is suggested to strengthen the cooperation among cluster enterprises and scientific research institutions,and improve enterprise innovation power;improve the mechanism of biological innovation and the level of industrialization of scientific research achievements;and actively guide the various types of biological innovation public service platform to participate in the construction of the soft environment of the cluster.

关 键 词：江苏省 生物医药产业 集群竞争力 灰色多指标评价模型 

分 类 号：R95[医药卫生—药学]